Krystexxa Interactions
There are 31 drugs known to interact with Krystexxa (pegloticase), along with 2 disease interactions. Of the total drug interactions, 5 are major, and 26 are moderate.
- View all 31 medications that may interact with Krystexxa
- View Krystexxa disease interactions (2)
Most frequently checked interactions
View interaction reports for Krystexxa (pegloticase) and the medicines listed below.
- Actemra (tocilizumab)
- allopurinol
- amlodipine
- Aranesp (darbepoetin alfa)
- Avastin (bevacizumab)
- Bumex (bumetanide)
- buspirone
- Bydureon (exenatide)
- carvedilol
- colchicine
- Eliquis (apixaban)
- Enbrel (etanercept)
- Entyvio (vedolizumab)
- febuxostat
- folic acid
- ibuprofen
- Lasix (furosemide)
- lisinopril
- magnesium oxide
- methotrexate
- metoprolol
- mycophenolate mofetil
- prednisone
- probenecid
- Remicade (infliximab)
- Stelara (ustekinumab)
- tramadol
- turmeric
- Tysabri (natalizumab)
- Vitamin D3 (cholecalciferol)
Krystexxa disease interactions
There are 2 disease interactions with Krystexxa (pegloticase) which include:
More about Krystexxa (pegloticase)
- Krystexxa consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (17)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antihyperuricemic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.